PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | C0079731|b-cell lymphoma |
| Sentences | 7 |
| PubMedID- 21188204 | In a review of eighteen hepatitis c infected patients with indolent b-cell lymphoma, an overall response rate of the lymphoma after antiviral treatment alone was 63% and 80%, respectively, in the group receiving interferon plus ribavirin and pegylated interferon plus ribavirin, respectively [28]. |
| PubMedID- 22736295 | Clinical outcome of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis c virus (hcv) infection in the rituximab era remains unclear. |
| PubMedID- 25381127 | The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection. |
| PubMedID- 20823454 | Hepatic toxicity and prognosis in hepatitis c virus-infected patients with diffuse large b-cell lymphoma treated with rituximab-containing chemotherapy regimens: a japanese multicenter analysis. |
| PubMedID- 25899771 | Prognostic impact of hepatitis c virus infection in patients with diffuse large b-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index. |
| PubMedID- 23465418 | Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection. |
| PubMedID- 24270404 | Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi. |
Page: 1